Use of human placenta hydrolysate in therapy for endometrial dysfunction

I. V Kuznetsova; Yu. B Uspenskaya; M. A Kovalenko

doi:10.17816/aog35464

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2014, Vol. 1 ›› Issue (1) : 22 -24. DOI: 10.17816/aog35464

Original study articles

research-article

Use of human placenta hydrolysate in therapy for endometrial dysfunction

Author information +

History +

PDF

Abstract

Open comparative randomized study of human placenta hydrolysate (Laennec®) efficiency in patients with endometrial proliferative failure demonstrated its efficiency in restoration of the endometrial regenerative potential, normalization of ovarian function, and improvement of pregnancy outcomes in women with infertility and miscarriages. The efficiency of placental hydrolysate was higher than that of immunomodulators and vitamins and the effect was more lasting. Hence, human placenta hydrolysate effectively prepared women with sterility and habitual fetal loss syndrome to pregnancy.

Keywords

chronic endometritis / infertility / fetal loss / endometrial dysfunction / placenta hydrolysate / Laennec®

Cite this article

Download citation ▾

I. V Kuznetsova, Yu. B Uspenskaya, M. A Kovalenko. Use of human placenta hydrolysate in therapy for endometrial dysfunction. V.F.Snegirev Archives of Obstetrics and Gynecology, 2014, 1(1): 22-24 DOI:10.17816/aog35464

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Пасман Н.М., Черных Е.Р., Хонина Е.А., Дударева А.В., Тихонова М.А., Останин А.А. и др. Иммунный статус женщин группы высокого риска по преждевременному прерыванию беременности. Вопросы гинекологии, акушерства и перинатологии, 2010; 9(4): 28-32.

[2]	Громова О.А., Торшин И.Ю., Диброва Е.А., Каримова И.М., Гилельс А.В., Кустова И.А. Мировой опыт применения препаратов из плаценты человека: результаты клинических и экспериментальных исследований. Обзор. Пластическая хирургия и косметология, 2011; 3: 385-576.